BriaCell Therapeutics Corp Ordinary Shares BCTX 深 滬
已收盤 09-20 16:00:00 美东时间
0.649
+0.047
+7.74%
華盛通- 最 高0.66
- 今 開0.591
- 成交量 288.58万股
- 最 低 0.57
- 昨 收 0.6024
- 總市值 1993.06万
- 52周最高 6.36
- 市盈率 靜 --
- 換手率 9.40%
- 52周最低 0.4641
- 委 比 46.00%
- 總股本 3070.97万
- 歷史最高 12.4039
- 量 比 0.53
- 振 幅 14.94%
- 歷史最低 0.4641
- 每 手 1
- 風險率 1.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BriaCell Completes $8.5 Million Share Offering
BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics C...
09-13 04:38
BriaCell Therapeutics prices $8.5M equity offering
BriaCell Therapeutics (NASDAQ:BCTX) said it has priced its offering of 12.33M shares or pre-funded warrants at $0.69 apiece. The company expects total gross proceeds of ~$8.5M. Shares of the company w...
09-12 01:17
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $18 price target.
09-12 01:04
BriaCell stock rockets 150% on positive Phase 2 data for Bria-IMT
Shares of BriaCell Therapeutics (NASDAQ:BCTX) soared 150% in morning trading Wednesday after the company reported positive overall survival data from a Phase 2 study for its therapy Bria-IMT in the tr...
09-11 22:36
Market-Moving News for September 11th
BCTX: 143% | BriaCell Announces Phase 2 Data Showing Median Overall Survival Of 15.6 Months In Bria-IMT Study For Metastatic Breast Cancer, Comparing Favorably To 6.7-9.3 Months In Literature; No Drug-Related
09-11 20:39
BeiGene GAAP ADS of -$1.15 beats by $1.20, revenue of $929.17M beats by $119.98M
BeiGene press release (NASDAQ:BGNE): Q2 GAAP ADS of -$1.15 beats by $1.20. Revenue of $929.17M (+56.1% Y/Y) beats by $119.98M. More on BeiGene BeiGene: Navigating Patent Disputes Towards Profitability...
08-07 18:21
BriaCell Touts Breakthrough in Breast Cancer Survival
BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics h...
07-18 20:50
BeiGene names Aaron Rosenberg as CFO
BeiGene (NASDAQ:BGNE) said it has appointed Aaron Rosenberg as CFO, effective July 22. Rosenberg, who will succeed Julia Wang, was most recently senior vice president and corporate treasurer of Merck ...
07-18 18:38
BriaCell Subsidiary BriaPro Releases Financial Reports
BriaCell Therapeutics (BCT) has issued an announcement. BriaPro Therapeutics Co...
06-15 05:14
BriaCell Presents Clinical Efficacy Data at ASCO 2024
BriaCell doubles Progression-Free-Survival (PFS) and Clinical Benefit Rate vs h...
06-03 20:00
